Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Charles River Laboratories Intl (NY: CRL ) 214.79 -6.83 (-3.08%) Official Closing Price Updated: 7:00 PM EDT, Jun 7, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Charles River Laboratories Intl < Previous 1 2 3 4 5 6 7 Next > Charles River Laboratories Expands Access to CRADL® Contract Vivarium Space in Somerville June 06, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories Announces Development of Nonclinical Virtual Control Groups with Sanofi to Reduce the Use of Animals in Research June 04, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories to Present at William Blair and Jefferies Conferences June 03, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy Development May 30, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories Announces First-Quarter 2024 Results May 09, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Launches Viral Vector Reference Materials to Streamline the Transition to GMP May 02, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally April 22, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing April 16, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call April 12, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology April 11, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics April 09, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River to Perform Plasmid Production for Ship of Theseus April 04, 2024 From Charles River Laboratories International, Inc. Via Business Wire CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. is Investigating Charles River Laboratories International, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm April 02, 2024 From Bragar Eagel & Squire Via GlobeNewswire Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024 April 01, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories Publishes 2023 Corporate Citizenship Report March 27, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine March 21, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River and Navega Therapeutics Announce Comprehensive Gene Therapy Manufacturing Collaboration March 14, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories to Present at Barclays Global Healthcare Conference March 12, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River and Wheeler Bio Complete Agreement to Accelerate the Journey from Discovery and CMC Development to Manufacturing February 21, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Collaborates with Pluristyx, Expanding its Portfolio of Human Pluripotent Stem Cells February 20, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Introduces the First Rapid Animal-Free Bacterial Endotoxin Test January 29, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories Adds Reshema Kemps-Polanco to Board of Directors January 24, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories Schedules Fourth-Quarter 2023 Earnings and 2024 Guidance Release and Conference Call January 23, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Launches Rep/Cap Plasmids to Streamline Adeno-Associated Viral Vector Manufacturing January 16, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories to Present at J.P. Morgan Healthcare Conference January 08, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River and Vertex Pharmaceuticals Reach Important Milestone in Cell Therapy Manufacturing Collaboration December 18, 2023 From Charles River Laboratories International, Inc. Via Business Wire Charles River Finalizes Agreement with CELLphenomics, Expanding 3D In Vitro Services for Cancer Therapy Drug Screening December 12, 2023 From Charles River Laboratories International, Inc. Via Business Wire Charles River and Genetic Cures for Kids Announce Gene Therapy Manufacturing Collaboration November 28, 2023 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories to Present at Evercore ISI Investor Conference November 27, 2023 From Charles River Laboratories International, Inc. Via Business Wire Charles River Introduces CliniPrime Cryopreserved Leukopaks, Expanding Suite of GMP-Compliant Cellular Products November 16, 2023 From Charles River Laboratories International, Inc. Via Business Wire < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.